Foresight backs Fertility Focus with £1.25m investment

Jan 29, 2019 ·

Shutterstock 1074524186 898x505

Foresight Group LLP has announced a £1.25m growth capital investment into Fertility Focus Limited (FFL), a fertility monitoring technology company that has developed OvuSense, a registered medical device that enables women to predict ovulation.

The investment was led by Foresight on behalf of Foresight VCT plc and Foresight 4 VCT plc as part of a larger £2m funding round, supported by new and existing investors including private high net-worth individuals.

Based in Warwick, FFL was established in 2005 to commercialise the intellectual property developed by a team from Bristol University that identified the ability to determine and predict ovulation with a high degree of accuracy by monitoring subtle changes in body temperature.

Leveraging this knowledge, FFL developed OvuSense, a sensor that monitors core body temperature. When combined with the proprietary algorithm available on the company’s smartphone app, OvuSense is able to predict ovulation up to 24 hours in advance in real time and detect ovulation in advance with 99% accuracy.

Read Complete Article

RT @swiftscaleco: Great to see the Tech for Social impact sector growing so quickly in the UK with 490 startups raising over £1B in VC fund…

I am deeply frustrated about the delay to Crossrail. @TfL & @transportgovuk will continue to hold new leadership to…

Challenge your #AI skills and show how they can change the world of business at the #HackXLR8 hackathon during #LTW…

Facebook open sources C++ F14 hash table

Cabinet ministers go public to deny leaking details of Huawei affair as Theresa May orders investigation